LV12149B - 5-CHARACTERIZED MICROPHENOL ACID 4-AMINOUTS - Google Patents

5-CHARACTERIZED MICROPHENOL ACID 4-AMINOUTS Download PDF

Info

Publication number
LV12149B
LV12149B LVP-98-157A LV980157A LV12149B LV 12149 B LV12149 B LV 12149B LV 980157 A LV980157 A LV 980157A LV 12149 B LV12149 B LV 12149B
Authority
LV
Latvia
Prior art keywords
formula
methyl
hydrogen
compound
alkyl
Prior art date
Application number
LVP-98-157A
Other languages
English (en)
Latvian (lv)
Other versions
LV12149A (lv
Inventor
Dean R. Artis
Todd R. Elworthy
Ronald C. HAWLEY
David G. Loughhead
David J. Morgans Jr.
Peter H. Nelson
John W. Patterson Jr.
Eric B. Sjogren
David B. Smith
Ann Marie WALTOS
Robert J. Weikert
Alicia C. Garcia
Mario F. Zertuche
Fidencio F. Andrade
Maria T. L. Hernandez
Fransisco X. T. MURRA
Teresa A. T. Martin
Original Assignee
Syntex (U.S.A.) Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex (U.S.A.) Inc. filed Critical Syntex (U.S.A.) Inc.
Publication of LV12149A publication Critical patent/LV12149A/xx
Publication of LV12149B publication Critical patent/LV12149B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-98-157A 1994-02-18 1998-07-27 5-CHARACTERIZED MICROPHENOL ACID 4-AMINOUTS LV12149B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/198,732 US5512568A (en) 1994-02-18 1994-02-18 Method of using 4-amino derivatives of 5-substituted mycophenolic acid

Publications (2)

Publication Number Publication Date
LV12149A LV12149A (lv) 1998-10-20
LV12149B true LV12149B (en) 1998-12-20

Family

ID=22734572

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-157A LV12149B (en) 1994-02-18 1998-07-27 5-CHARACTERIZED MICROPHENOL ACID 4-AMINOUTS

Country Status (22)

Country Link
US (2) US5512568A (pt)
EP (1) EP0745072B1 (pt)
JP (1) JPH09509173A (pt)
CN (1) CN1141039A (pt)
AT (1) ATE165826T1 (pt)
AU (1) AU1875395A (pt)
BR (1) BR9506838A (pt)
CA (1) CA2183531A1 (pt)
CO (1) CO4340732A1 (pt)
DE (1) DE69502380T2 (pt)
DK (1) DK0745072T3 (pt)
ES (1) ES2116078T3 (pt)
FI (1) FI963220A (pt)
HK (1) HK1010784A1 (pt)
IL (1) IL112666A (pt)
LV (1) LV12149B (pt)
MX (1) MX9603484A (pt)
PH (1) PH31426A (pt)
SI (1) SI0745072T1 (pt)
TW (1) TW438788B (pt)
WO (1) WO1995022537A2 (pt)
ZA (1) ZA951293B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6811998B2 (en) * 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
US20050187170A1 (en) * 2003-06-16 2005-08-25 Biocryst Pharmaceuticals, Inc. Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US10603299B2 (en) 2016-06-02 2020-03-31 Steven Baranowitz Prevention and treatment of viral infections
CA3026241A1 (en) 2016-06-02 2017-12-07 Steven Baranowitz Prevention and treatment of viral infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5542995B2 (pt) * 1972-02-24 1980-11-04
US3825571A (en) * 1971-07-31 1974-07-23 Chugai Pharmaceutical Co Ltd Mycophenolic acid derivatives
JPS5529994B2 (pt) * 1972-03-02 1980-08-07
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4861776A (en) * 1987-01-30 1989-08-29 Syntex (U.S.A) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4727069A (en) * 1987-01-30 1988-02-23 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
JPH0637486B2 (ja) * 1988-05-18 1994-05-18 三共株式会社 新規抗生物質フタレキシンおよびその製造法
US5247083A (en) * 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid
US5380879A (en) * 1994-02-18 1995-01-10 Syntex (U.S.A.) Inc. Derivatives of mycophenolic acid

Also Published As

Publication number Publication date
ATE165826T1 (de) 1998-05-15
CN1141039A (zh) 1997-01-22
FI963220A0 (fi) 1996-08-16
FI963220A (fi) 1996-10-16
EP0745072A1 (en) 1996-12-04
ES2116078T3 (es) 1998-07-01
IL112666A0 (en) 1995-05-26
EP0745072B1 (en) 1998-05-06
AU1875395A (en) 1995-09-04
WO1995022537A2 (en) 1995-08-24
IL112666A (en) 2000-01-31
US5538969A (en) 1996-07-23
DK0745072T3 (da) 1999-01-18
DE69502380T2 (de) 1998-10-08
CO4340732A1 (es) 1996-07-30
ZA951293B (en) 1996-08-16
BR9506838A (pt) 1997-09-30
PH31426A (en) 1998-10-29
SI0745072T1 (en) 1998-10-31
TW438788B (en) 2001-06-07
CA2183531A1 (en) 1995-08-24
HK1010784A1 (en) 1999-06-25
US5512568A (en) 1996-04-30
LV12149A (lv) 1998-10-20
WO1995022537A3 (en) 1995-10-26
JPH09509173A (ja) 1997-09-16
MX9603484A (es) 1998-01-31
DE69502380D1 (de) 1998-06-10

Similar Documents

Publication Publication Date Title
US5536747A (en) 6-substituted mycophenolic acid and derivatives
US5493030A (en) 5-substituted derivatives of mycophenolic acid
US5380879A (en) Derivatives of mycophenolic acid
US7456162B2 (en) Benzofuran derivatives, their production and use
US20040167171A1 (en) Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
CA2291026A1 (en) Heterocyclic compounds, their production and use
EP0338782A1 (en) Benzofuran derivatives
US5525602A (en) Method of using 4-amino 6-substituted mycophenolic acid and derivatives
LV12149B (en) 5-CHARACTERIZED MICROPHENOL ACID 4-AMINOUTS
US5087638A (en) Benzofuran derivatives
JP4357802B2 (ja) ベンゼン環縮合５員複素環式化合物、その製造法および用途
US4778805A (en) 4,7-benzofurandione derivatives useful as inhibitors of leukotriene synthesis
US4912131A (en) 4,7-diacyloxybenzofuran derivatives
JP3553442B2 (ja) ベンゾフラン誘導体、その製造法および用途
JP4364467B2 (ja) ベンゾフラン誘導体、その製造法および用途
EP0295851A1 (en) 4,7-diacyloxybenzofuran derivatives
EP0301692A2 (en) 4,7-Benzofurandione derivatives